TGA approves Pfizer vaccine for kids aged 12-15 years old

The Therapeutics Goods Administration decided to approve the vaccine for kids late last night.

| More on:
Female patient receives Pfizer covid vaccine administered by female doctor

Image Source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Pfizer Inc. (NYSE: PFE) COVID-19 vaccine has been approved for use in children aged 12-15 years in Australia.

The Therapeutics Goods Administration (TGA) made the decision late last night. Previously, COVID vaccines were only approved for those over the age of 16.

The TGA said in a statement:

"(Approval) has been made following careful evaluation of the available data supporting safety and efficacy, including clinical studies with adolescents 12 to 15 years of age."

The highly infectious delta variant is spreading in Australia, including in children. This is unlike previous strains, so today's news will provide options for worried parents.

However, the TGA says:

"Continued approval depends on the evidence of longer-term efficacy and safety from ongoing clinical trials and post-market assessment."

Pfizer replaces AstraZeneca as vaccine du jour

Australia is ranked last for the percentage of people fully vaccinated in the Organisation for Economic Co-operation and Development (OECD), and second last for people who have just one dose of the vaccine.

https://ourworldindata.org/covid-vaccinations

The federal government was relying on the bulk of supply to come from locally CSL Limited (ASX: CSL) manufactured AstraZeneca plc (LON: AZN).

However, emerging evidence of an extremely rare blood clotting disorder caused by the vaccine led to the government's expert advisory body, ATAGI, to recommend only those aged over 50, later 60, should take the vaccine.

Large swathes of Australians, including older residents, are reluctant to take the vaccine. Instead, they are waiting for more Pfizer vaccine.

The problem is we have too much AstraZeneca and not enough Pfizer vaccine.

The government acted to double the supply of Pfizer, as well as order Moderna Inc (NASDAQ: MRNA) vaccine as well. The bulk of this additional supply will arrive in the fourth quarter of this year.

The federal government has indemnified GPs who administer AstraZeneca in an attempt to get more jabs in arms.

It is available to those under 40 years who choose to take the jab at their doctor's office.

While today's news is positive, there is no expectation that children will be able to get inoculated any time soon.

Federal Health Minister, Greg Hunt said:

"Our plans are in place to roll out what is more likely, on the early advice I have, is that they will fast-track vaccines for 12- to 15-year-olds for the immunocompromised children or those with underlying health conditions," Hunt told Channel 7.

Other children will need to wait, along with adults, for more supply of Pfizer most likely in September or October.

The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of and has recommended CSL Ltd. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended Moderna Inc. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Coronavirus News

Man with his hand on his face looking at a falling share price chart on a tablet.
Share Market News

ASX 200 stocks dive 2.4% in worst trading day since Ukraine crisis hit

It's not a good start to the week for the market.

Read more »

A woman looks nervous and uncertain holding a hand to her chin while looking at a paper cut out of a plane that she's holding in her other hand. representing the falling Air New Zealand share price today
Travel Shares

Borders just reopened so why is the Flight Centre (ASX:FLT) share price falling today?

Experts believe it may take several years for tourism levels to rebound to pre-pandemic numbers.

Read more »

A worker in hi vis gear holds his hand up saying no.
Coronavirus News

Own BHP (ASX:BHP) shares? Here's how the ASX 200 miner is battling COVID

Mining unions have not generally supported mandatory vaccinations.

Read more »

Female worker sitting desk with head in hand and looking fed up
Coronavirus News

Here's what Rio Tinto (ASX:RIO) boss says is 'causing some challenges' right now

The Omicron variant is spreading in Western Australia.

Read more »

A man wearing a mask punches the air with joy after getting a negative COVID result on a rapid antigen test.
Coronavirus News

Why are ASX COVID test shares climbing today?

COVID-19 tests are in focus again today.

Read more »

a girl stands in an apple orchard holding two red apples in raised arms with a happy, celebratory look on her face with a large smile and a pretty country background to the picture.
Economy

CBA reveals the Australian economy's leading state amid COVID surge

The states and territories have all been impacted by the pandemic.

Read more »

Rapid Antigen Test taking place.
Share Market News

Why is Ellume hitting headlines today?

Brisbane-based diagnostics developer Ellume is back in the headlines.

Read more »

A woman looks quizzical as she looks at a graph of the share market.
Share Market News

Inghams (ASX:ING) share price sinks as Omicron bites

Inghams shares are down as COVID hurts its operations.

Read more »